Intrinsic Value
Cyclacel Pharmaceuticals, Inc. (CYCC)
$2
-0.49 (-19.68%)
| Enterprise Value | - |
|---|---|
| Net Debt | -3.34 |
| Equity Value | - |
| Shares Outstanding | 0.85 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt